Stay updated with breaking news from Ben Brahim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Positive data on key clinical candidates delivered in 2022 Promising outlook for 2023 as industry interest in therapeutic cancer vaccines and oncolytic viruses gains significant momentum TG4050:New
Study will evaluate the intravenous administration of company’s multi-armed immunotherapy - News - PharmaTimes
In Tunisia, 12 years after the revolution, citizens are still asking, "How do you expect me to make a living?"
The analysis showed a clear benefit for patients with anogenital cancers who received the vaccine plus a checkpoint inhibitor over those who received only a checkpoint inhibitor.
Based on promising progression-free survival (PFS) interim analysis, trial to continue and an optimized number of patients to be randomized in the trial Management to host webcast presentation of